Overview
Nuclear magnetic resonance imaging (NMR) is used in pediatric brain tumors for purposes of diagnosis, evaluation of response to treatments, and monitoring of patients in follow-up. Through conventional imaging techniques it remains difficult to differentiate tumor recurrence from pseudo-progression or other iatrogenic changes after radiotherapy or chemotherapy, but it remains a relevant and essential clinical need for patient management.
Eligibility
Inclusion Criteria:
- children and/or adolescents (≤18 years) diagnosed with brain tumor.
- children who underwent the contemporary adjuvant therapy protocol of post-surgical chemo and radiotherapy.
Exclusion Criteria:
- patients >18 years